Feride Frech

TL;DR: The aim was to perform a systematic review of the methods currently being used to assess adherence and persistence in pharmacoepidemiological and pharmacoeconomic studies using automated databases.

TL;DR: Using Rome I symptom criteria, it is found that IBS is associated with a broad pattern of increased health care use and costs and the severity of abdominal pain/discomfort is a significant predictor of health careUse and costs for patients with IBS compared with non-IBS subjects.

TL;DR: IBS was associated with a 21% reduction in work productivity, equivalent to working less than 4 days in a 5-day workweek, and employees with IBS had significantly lower scores on all domains of the SF-36, indicating poorer functional outcomes.

TL;DR: Irritable bowel syndrome is a significant financial burden on the employer that arises from an increase in direct and indirect costs compared with the control group.

TL;DR: A number of instruments available to measure outcome in dermatological conditions but none have been developed specifically for AD, and most measure symptoms and/or daily functioning, which are potential influences on quality of life (QoL) rather than assessments of the construct itself.